ada 2025 retatrutide results 2026: Revolution Phase 2 trial results demonstrate

People with cirrhosis or significant liver dysfunction should avoid supplements without hepatologist guidance

Methionine An essential amino acid that helps break down fats and prevents fat accumulation in the liver

The evidence consistently identifies several factors that increase risk further: Higher doses (the weight-loss doses of semaglutide and tirzepatide carry higher risk than the lower diabetic doses) Longer duration of treatment Faster rate of weight loss Pre-existing gallstones even asymptomatic ones found on a previous scan Female sex, age over 40, and family history of gallstones (the standard baseline risk factors, amplified by GLP-1 therapy) If several of these apply to you, the risk-benefit balance of your treatment plan is worth a structured discussion

After cholecystectomy, your liver still produces bile, but it drips continuously into your intestines rather than being released in controlled pulses

Therefore, these guidelines represent a conditional GRADE recommendation for clinical practice